Last Price
0.053
Today's Change
-0.004 (7.01%)
Day's Change
0.053 - 0.056
Trading Volume
75,461
Overview
Market Cap
8 Million
Shares Outstanding
156 Million
Avg Volume
457,580
Avg Price (50 Days)
0.06
Avg Price (200 Days)
0.05
PE Ratio
-1.77
EPS
-0.03
Earnings Announcement
26-Jul-2024
Previous Close
0.06
Open
0.06
Day's Range
0.053 - 0.056
Year Range
0.018 - 0.17
Trading Volume
75,461
Price Change Highlight
1 Day Change
-7.02%
5 Day Change
1.92%
1 Month Change
-5.36%
3 Month Change
-43.62%
6 Month Change
130.43%
Ytd Change
140.91%
1 Year Change
1.92%
3 Year Change
-83.69%
5 Year Change
-77.45%
10 Year Change
-77.45%
Max Change
-77.45%
News and Blogs
No result.
Company Profile
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
Nyrada Inc., a pre-clinical stage drug development company, engages in the development of small molecule drugs for cardiovascular, neurodegenerative, and chronic inflammatory diseases. Its products in the drug development stage include PCSK9 inhibitor for the treatment of high blood LDL-cholesterol levels in patients poorly responsive to or unable to take statin drugs; a neuroprotectant drug to reduce the disability in patients with ischaemic stroke and traumatic brain injury; a drug to treat pain associated with peripheral nerve damage; and a drug to treat autoimmune diseases, such as psoriasis. The company has collaboration with Walter Reed Army Institute of Research and University of New South Wales, Sydney. Nyrada Inc. was incorporated in 2017 and is based in Gordon, Australia.
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Apps
Top Articles
1
CEO Morning Brief
#
Stock
Score
Daily Stocks
Stock
Last
Change
Volume
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
